Literature DB >> 11724803

Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.

Elena I Deryugina1, Boris I Ratnikov, Tanya I Postnova, Dmitri V Rozanov, Alex Y Strongin.   

Abstract

Recently, we have shown that membrane type 1 matrix metalloproteinase (MT1-MMP) exhibits integrin convertase activity. Similar to furin-like proprotein convertases, MT1-MMP directly processes a single chain precursor of alpha(v) integrin subunit (pro-alpha(v)) into the heavy and light alpha-chains connected by a disulfide bridge. To evaluate functionality of MT1-MMP-processed integrins, we examined breast carcinoma MCF7 cells co-expressing alpha(v)beta(3) integrin with either the wild type or mutant MT1-MMP in a variety of migration and adhesion tests. Specific inhibitors of proprotein convertases and MMP were employed in our cell system to attenuate the individual pathways of pro-alpha(v) maturation. We present evidence that MT1-MMP cleavage of pro-alpha(v) in the cells did not affect RGD-ligand binding of the resulting alpha(v)beta(3) integrin but enhanced outside-in signal transduction through a focal adhesion kinase pathway. Enhanced tyrosine phosphorylation of focal adhesion kinase in cells co-expressing MT1-MMP and alpha(v)beta(3) integrin contributed to efficient adhesion and, especially, migration of cells on vitronectin, a ligand of alpha(v)beta(3) integrin. These mechanisms underscore the significance of a coordinated interplay between MT1-MMP and alpha(v)beta(3) integrin in tumor cells and identify downstream signaling pathways resulting from their interactions. Regulation of integrin maturation and functionality may be an important role of MT1-MMP in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724803     DOI: 10.1074/jbc.M110269200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.

Authors:  Albert G Remacle; Vladislav S Golubkov; Sergey A Shiryaev; Russell Dahl; John L Stebbins; Andrei V Chernov; Anton V Cheltsov; Maurizio Pellecchia; Alex Y Strongin
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

Review 2.  Integrins in mammary gland development and differentiation of mammary epithelium.

Authors:  Ilaria Taddei; Marisa M Faraldo; Jérôme Teulière; Marie-Ange Deugnier; Jean Paul Thiery; Marina A Glukhova
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

3.  MT1-MMP-mediated basement membrane remodeling modulates renal development.

Authors:  Karen S Riggins; Glenda Mernaugh; Yan Su; Vito Quaranta; Naohiko Koshikawa; Motoharu Seiki; Ambra Pozzi; Roy Zent
Journal:  Exp Cell Res       Date:  2010-08-19       Impact factor: 3.905

4.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Authors:  Ying-Chi Ip; Siu-Tim Cheung; Ka-Ling Leung; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 5.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

6.  MT1-MMP Binds Membranes by Opposite Tips of Its β Propeller to Position It for Pericellular Proteolysis.

Authors:  Tara C Marcink; Jayce A Simoncic; Bo An; Anna M Knapinska; Yan G Fulcher; Narahari Akkaladevi; Gregg B Fields; Steven R Van Doren
Journal:  Structure       Date:  2018-11-21       Impact factor: 5.006

7.  Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2-based antagonists for cancer therapy.

Authors:  Gal Yosef; Valeria Arkadash; Niv Papo
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

8.  Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7).

Authors:  Vladislav S Golubkov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 9.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

10.  MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.

Authors:  Krishna Kumar Veeravalli; Chandramu Chetty; Shivani Ponnala; Christopher S Gondi; Sajani S Lakka; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.